SCHEMBL12801079

SCHEMBL12801079

CC(C)(COc1ccc(-c2ccnc(Nc3ccc(N4CCOCC4)cc3)n2)cc1N)C(=O)O

nearest known ligand 0.65

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
JAK2 O60674 20/20 0.65
JAK3 P52333 12/20 0.60
TYK2 P29597 5/20 0.57
JAK1 P23458 5/20 0.57
HDAC1 Q13547 2/20 0.56
HDAC3 O15379 1/20 0.56
NCOR1 O75376 1/20 0.56
HDAC2 Q92769 1/20 0.56
HDAC8 Q9BY41 1/20 0.56
HDAC6 Q9UBN7 1/20 0.56
BMPR1B O00238 1/20 0.55
PLK4 O00444 1/20 0.55
CIT O14578 1/20 0.55
GAK O14976 1/20 0.55
OPA1 O60313 1/20 0.55
ROCK2 O75116 1/20 0.55
STK16 O75716 1/20 0.55
PRKD3 O94806 1/20 0.55
CSNK2A2 P19784 1/20 0.55
CDK2 P24941 1/20 0.55

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL12800910 0.93 JAK2 (0.67) JAK2JAK3TYK2JAK1HDAC1
SCHEMBL12801337 0.90 JAK2 (0.69) JAK2JAK3TYK2JAK1HDAC1
SCHEMBL1667298 0.88 JAK2 (0.61) JAK2JAK3TYK2JAK1HDAC1
SCHEMBL12800357 0.87 JAK2 (0.57) JAK2JAK3TYK2JAK1HDAC1
SCHEMBL12801615 0.85 JAK2 (0.69) JAK2JAK3TYK2JAK1HDAC1
SCHEMBL12801310 0.85 JAK2 (0.72) JAK2JAK3TYK2JAK1HDAC1
SCHEMBL12801590 0.84 JAK2 (0.66) JAK2JAK3TYK2JAK1HDAC1
SCHEMBL12801653 0.84 JAK2 (0.85) JAK2JAK3TYK2JAK1HDAC1
SCHEMBL12801297 0.84 JAK2 (0.63) JAK2JAK3TYK2JAK1HDAC1
SCHEMBL12801611 0.84 JAK2 (0.70) JAK2JAK3TYK2JAK1HDAC1

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 1 patent. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
WO-2011046970-A1 AMINO - PYRIMIDINE COMPOUNDS AS INHIBITORS OF TBKL AND/OR IKK EPSILON MYREXIS, INC. (US) 2011-04-21 WO disclosed